Pfizer Inc (PFE)
30.78
+0.60
(+1.97%)
USD |
NYSE |
Jul 26, 16:00
30.73
-0.04
(-0.15%)
After-Hours: 20:00
Pfizer Price to Book Value: 1.890 for July 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 25, 2024 | 1.853 |
| July 24, 2024 | 1.841 |
| July 23, 2024 | 1.812 |
| July 22, 2024 | 1.818 |
| July 19, 2024 | 1.840 |
| July 18, 2024 | 1.824 |
| July 17, 2024 | 1.844 |
| July 16, 2024 | 1.812 |
| July 15, 2024 | 1.787 |
| July 12, 2024 | 1.776 |
| July 11, 2024 | 1.760 |
| July 10, 2024 | 1.741 |
| July 09, 2024 | 1.702 |
| July 08, 2024 | 1.715 |
| July 05, 2024 | 1.722 |
| July 03, 2024 | 1.701 |
| July 02, 2024 | 1.709 |
| July 01, 2024 | 1.733 |
| June 28, 2024 | 1.718 |
| June 27, 2024 | 1.707 |
| June 26, 2024 | 1.684 |
| June 25, 2024 | 1.719 |
| June 24, 2024 | 1.742 |
| June 21, 2024 | 1.703 |
| June 20, 2024 | 1.703 |
| Date | Value |
|---|---|
| June 18, 2024 | 1.683 |
| June 17, 2024 | 1.657 |
| June 14, 2024 | 1.690 |
| June 13, 2024 | 1.698 |
| June 12, 2024 | 1.698 |
| June 11, 2024 | 1.721 |
| June 10, 2024 | 1.724 |
| June 07, 2024 | 1.755 |
| June 06, 2024 | 1.768 |
| June 05, 2024 | 1.814 |
| June 04, 2024 | 1.811 |
| June 03, 2024 | 1.800 |
| May 31, 2024 | 1.760 |
| May 30, 2024 | 1.732 |
| May 29, 2024 | 1.708 |
| May 28, 2024 | 1.738 |
| May 24, 2024 | 1.773 |
| May 23, 2024 | 1.762 |
| May 22, 2024 | 1.818 |
| May 21, 2024 | 1.754 |
| May 20, 2024 | 1.752 |
| May 17, 2024 | 1.759 |
| May 16, 2024 | 1.776 |
| May 15, 2024 | 1.770 |
| May 14, 2024 | 1.743 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.522
Minimum
Dec 14 2023
4.542
Maximum
Dec 16 2021
2.830
Average
3.018
Median
Price to Book Value Benchmarks
| Amgen Inc | 35.75 |
| Johnson & Johnson | 5.522 |
| Sarepta Therapeutics Inc | 14.19 |
| Viking Therapeutics Inc | 7.778 |
| Moderna Inc | 3.653 |
Price to Book Value Related Metrics
| PS Ratio | 3.170 |
| Price to Free Cash Flow | 34.21 |
| Price | 30.78 |
| Earnings Yield | -0.19% |
| Market Cap | 174.39B |
| Operating PE Ratio | 146.53 |
| Normalized PE Ratio | 51.40 |